# A Study of HS-10380 in Chinese Participants

> **NCT05480592** · PHASE1 · UNKNOWN · sponsor: **Jiangsu Hansoh Pharmaceutical Co., Ltd.** · enrollment: 76 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** HS-10380
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05480592
- **Lead sponsor:** Jiangsu Hansoh Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-07-30
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2023-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05480592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05480592, "A Study of HS-10380 in Chinese Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05480592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*